ProShare Advisors’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-19,955
| Closed | -$7.15K | – | 2105 |
|
2024
Q2 | $7.15K | Sell |
19,955
-6,811
| -25% | -$2.44K | ﹤0.01% | 1840 |
|
2024
Q1 | $17.9K | Buy |
26,766
+1,864
| +7% | +$1.25K | ﹤0.01% | 1976 |
|
2023
Q4 | $13.5K | Sell |
24,902
-5,416
| -18% | -$2.94K | ﹤0.01% | 1937 |
|
2023
Q3 | $18.2K | Buy |
30,318
+443
| +1% | +$266 | ﹤0.01% | 1791 |
|
2023
Q2 | $38.8K | Buy |
29,875
+2,444
| +9% | +$3.18K | ﹤0.01% | 1794 |
|
2023
Q1 | $48.3K | Sell |
27,431
-3,341
| -11% | -$5.88K | ﹤0.01% | 1675 |
|
2022
Q4 | $96.6K | Buy |
30,772
+3,511
| +13% | +$11K | ﹤0.01% | 1656 |
|
2022
Q3 | $134K | Buy |
27,261
+2,382
| +10% | +$11.7K | ﹤0.01% | 1494 |
|
2022
Q2 | $104K | Sell |
24,879
-12,515
| -33% | -$52.3K | ﹤0.01% | 1606 |
|
2022
Q1 | $217K | Sell |
37,394
-9,058
| -19% | -$52.6K | ﹤0.01% | 1840 |
|
2021
Q4 | $348K | Buy |
46,452
+185
| +0.4% | +$1.39K | ﹤0.01% | 1697 |
|
2021
Q3 | $417K | Sell |
46,267
-10,081
| -18% | -$90.9K | ﹤0.01% | 1316 |
|
2021
Q2 | $674K | Buy |
56,348
+5,760
| +11% | +$68.9K | ﹤0.01% | 1304 |
|
2021
Q1 | $634K | Buy |
50,588
+3,256
| +7% | +$40.8K | ﹤0.01% | 1291 |
|
2020
Q4 | $739K | Buy |
47,332
+10,496
| +28% | +$164K | ﹤0.01% | 1021 |
|
2020
Q3 | $348K | Sell |
36,836
-1,325
| -3% | -$12.5K | ﹤0.01% | 1097 |
|
2020
Q2 | $342K | Buy |
38,161
+15,490
| +68% | +$139K | ﹤0.01% | 1155 |
|
2020
Q1 | $144K | Sell |
22,671
-17,973
| -44% | -$114K | ﹤0.01% | 1042 |
|
2019
Q4 | $340K | Sell |
40,644
-3,753
| -8% | -$31.4K | ﹤0.01% | 1268 |
|
2019
Q3 | $402K | Sell |
44,397
-31
| -0.1% | -$281 | ﹤0.01% | 1070 |
|
2019
Q2 | $478K | Sell |
44,428
-1,282
| -3% | -$13.8K | ﹤0.01% | 1032 |
|
2019
Q1 | $436K | Buy |
45,710
+415
| +0.9% | +$3.96K | ﹤0.01% | 1071 |
|
2018
Q4 | $520K | Sell |
45,295
-8,571
| -16% | -$98.4K | ﹤0.01% | 934 |
|
2018
Q3 | $913K | Sell |
53,866
-2,149
| -4% | -$36.4K | 0.01% | 862 |
|
2018
Q2 | $795K | Buy |
56,015
+6,218
| +12% | +$88.3K | 0.01% | 914 |
|
2018
Q1 | $946K | Sell |
49,797
-8,187
| -14% | -$156K | 0.01% | 845 |
|
2017
Q4 | $951K | Buy |
57,984
+5,193
| +10% | +$85.2K | 0.01% | 859 |
|
2017
Q3 | $792K | Buy |
52,791
+9,560
| +22% | +$143K | 0.01% | 792 |
|
2017
Q2 | $380K | Sell |
43,231
-2,590
| -6% | -$22.8K | ﹤0.01% | 1055 |
|
2017
Q1 | $238K | Sell |
45,821
-11,989
| -21% | -$62.3K | ﹤0.01% | 1362 |
|
2016
Q4 | $176K | Buy |
57,810
+6,422
| +12% | +$19.6K | ﹤0.01% | 1625 |
|
2016
Q3 | $238K | Sell |
51,388
-9,583
| -16% | -$44.4K | ﹤0.01% | 1260 |
|
2016
Q2 | $353K | Buy |
60,971
+365
| +0.6% | +$2.11K | ﹤0.01% | 1126 |
|
2016
Q1 | $367K | Sell |
60,606
-5,855
| -9% | -$35.5K | 0.01% | 1120 |
|
2015
Q4 | $607K | Buy |
66,461
+6,537
| +11% | +$59.7K | 0.01% | 948 |
|
2015
Q3 | $338K | Sell |
59,924
-4,455
| -7% | -$25.1K | ﹤0.01% | 1099 |
|
2015
Q2 | $714K | Sell |
64,379
-4,485
| -7% | -$49.7K | 0.01% | 932 |
|
2015
Q1 | $1.08M | Buy |
68,864
+8,969
| +15% | +$141K | 0.01% | 810 |
|
2014
Q4 | $911K | Sell |
59,895
-2,219
| -4% | -$33.8K | 0.01% | 906 |
|
2014
Q3 | $670K | Sell |
62,114
-12,263
| -16% | -$132K | 0.01% | 1235 |
|
2014
Q2 | $1.14M | Sell |
74,377
-35,451
| -32% | -$541K | 0.01% | 1100 |
|
2014
Q1 | $1.99M | Buy |
109,828
+78,162
| +247% | +$1.41M | 0.02% | 755 |
|
2013
Q4 | $440K | Sell |
31,666
-21,288
| -40% | -$296K | 0.01% | 1083 |
|
2013
Q3 | $555K | Buy |
52,954
+8,477
| +19% | +$88.8K | 0.01% | 1371 |
|
2013
Q2 | $347K | Buy |
+44,477
| New | +$347K | 0.01% | 1589 |
|